BSE Live
Jan 23, 16:01Prev. Close
169.95
Open Price
169.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:59Prev. Close
169.80
Open Price
170.51
Bid Price (Qty.)
163.27 (292)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Marksans Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 | |
| Total Share Capital | 40.93 | 50.93 | 50.93 | 51.93 | 53.43 | |
| Reserves and Surplus | 595.08 | 501.55 | 429.93 | 392.50 | 400.89 | |
| Total Reserves and Surplus | 595.08 | 501.55 | 429.93 | 392.50 | 400.89 | |
| Total Shareholders Funds | 636.01 | 552.48 | 480.86 | 444.43 | 454.32 | |
| Minority Interest | 13.11 | 10.22 | 9.55 | 6.25 | 8.36 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 10.79 | 7.03 | 6.01 | 4.11 | 0.00 | |
| Other Long Term Liabilities | 12.52 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 1.47 | 1.36 | 1.08 | 0.96 | 0.00 | |
| Total Non-Current Liabilities | 24.79 | 8.39 | 7.09 | 5.07 | 0.00 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 18.84 | 99.91 | 117.41 | 109.71 | 87.89 | |
| Trade Payables | 110.33 | 106.07 | 77.83 | 161.78 | 118.98 | |
| Other Current Liabilities | 70.72 | 25.81 | 19.12 | 3.82 | 0.68 | |
| Short Term Provisions | 28.86 | 0.84 | 20.32 | 20.74 | 51.88 | |
| Total Current Liabilities | 228.75 | 232.62 | 234.68 | 296.06 | 259.43 | |
| Total Capital And Liabilities | 902.67 | 803.71 | 732.19 | 751.81 | 722.12 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 230.01 | 198.08 | 186.37 | 164.50 | 164.14 | |
| Intangible Assets | 72.70 | 71.64 | 93.01 | 102.47 | 105.52 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.36 | 0.00 | |
| Fixed Assets | 302.72 | 269.73 | 279.38 | 267.34 | 269.65 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.63 | 1.25 | 1.45 | 0.00 | 1.91 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 10.41 | |
| Other Non-Current Assets | 5.73 | 1.29 | 0.82 | 0.59 | 0.00 | |
| Total Non-Current Assets | 309.08 | 272.27 | 281.65 | 267.92 | 281.97 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 241.84 | 293.25 | 218.12 | 190.09 | 167.79 | |
| Trade Receivables | 243.35 | 176.60 | 176.91 | 247.58 | 217.29 | |
| Cash And Cash Equivalents | 93.73 | 33.54 | 39.88 | 25.16 | 35.30 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 19.76 | |
| OtherCurrentAssets | 14.67 | 28.06 | 15.63 | 21.05 | 0.00 | |
| Total Current Assets | 593.59 | 531.44 | 450.54 | 483.88 | 440.15 | |
| Total Assets | 902.67 | 803.71 | 732.19 | 751.81 | 722.12 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 48.17 | 30.40 | 11.05 | 9.20 | 9.71 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y